Managed Healthcare Executive October 17, 2023
Peter Wehrwein, Managing Editor

Melissa Andel, M.P.P., of CommonHealth Solutions LLC, says there has been some retreat from earlier proposals for severe regulation to an emphasis on disclosure and transparency.

All legislative and political jockeying around tightening regulation of pharmacy benefit managers (PBMs) has reified into four bills, one in the House and three in the Senate that have emerged from three different committees. Today at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 meeting in Orlando, Melissa Andel, M.P.P., outlined the PBM legislation and shared insights into which provisions stand the best chance of surviving and becoming law.

In a Zoom interview with Managed Healthcare Executive prior to the meeting, Andel described some of the themes of the legislation.

The Senate bills...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Conferences / Podcast, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Regulations, Trends
Eli Lilly to invest $27B in manufacturing
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
How AI Drug Manufacturing Is Changing the Game
Radiopharmaceutical Manufacturing: A High-Stakes Race Against Time
Will Pharma Continue Efforts to Diversify Clinical Trials?

Share This Article